Sight Sciences announces $34M patent infringement verdict against Alcon

Sight Sciences (SGHT) announced that it received a positive jury trial verdict of $34M associated with the patent infringement case it filed on September 16, 2021 against Alcon (ALC), Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc. in the U.S. District Court for the District of Delaware. Sight Sciences asserted that Alcon’s and Ivantis’ sale of the Hydrus Microstent infringed three key patents. The verdict was announced on Friday, April 26, 2024, following a five-day jury trial. The jury found that Alcon willfully infringed all three Sight Sciences’ asserted patents and awarded monetary damages for past infringement. The monetary damages are comprised of $5.5 million in lost profits and $28.5 million in royalty damages for sales of the Hydrus Microstent for the period from its commercial launch through trial. The patents at issue were U.S. Patent Nos. 8,287,482, 9,370,443, and 11,389,328. The judge has not yet ruled on any potential enhancement of damages associated with the willfulness verdict or other remedies. Cooley LLP represented Sight Sciences. This verdict is subject to appeal.